Understanding weight loss in lung cancer patients
Investigating cancer-associated cachexia in genetic subtypes of lung cancer
This study is looking at why people with lung cancer sometimes lose weight and muscle without trying, and it hopes to find new ways to help improve their health and well-being by understanding the changes happening in their bodies.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11093312 on NIH RePORTER |
What this research studies
This research investigates cancer-associated cachexia, a condition where patients with lung cancer involuntarily lose muscle and fat. It aims to understand the metabolic changes that contribute to this weight loss and how different genetic subtypes of lung cancer may affect this process. By studying these mechanisms, the research seeks to identify potential new treatments that could improve the quality of life for patients suffering from cachexia. The approach includes analyzing metabolic alterations and inflammatory factors that drive this syndrome.
Who could benefit from this research
Good fit: Ideal candidates for this research are lung cancer patients experiencing involuntary weight loss and muscle wasting.
Not a fit: Patients with lung cancer who are not experiencing cachexia or significant weight loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments for cancer-associated cachexia, improving survival and quality of life for patients.
How similar studies have performed: Previous research has shown promise in understanding cachexia in cancer patients, but this specific approach focusing on genetic subtypes is relatively novel.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Cross, Michael — New York University School of Medicine
- Study coordinator: Cross, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.